openPR Logo
Press release

Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty - More Stocks Inside

05-19-2025 03:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid

In a market defined by uncertainty and shifting investor sentiment, a select group of penny stocks is making waves across healthcare, cybersecurity, biotech, and digital infrastructure. Companies like Healthcare Triangle (NASDAQ: HCTI), Sekur Private Data Ltd. (OTCQB: SWISF | CSE: SKUR), American Diversified Holdings Corp. (OTC: ADHC), and NuCana plc (NASDAQ: NCNA), among others herein, are demonstrating resilience and innovation, positioning themselves for potential upside. As investors scan the under-the-radar landscape for growth catalysts, these emerging players are drawing fresh attention with breakthrough technologies, regulatory momentum, and expanding market reach.

Healthcare Triangle, Inc. (NASDAQ: HCTI) continues advancing healthcare transformation, recently achieving HITRUST r2 Certification for its CloudEz Trademark , DataEz Trademark , and readabl.AI platforms-signaling top-tier data protection and compliance standards. With a focus on digital agility, security, and interoperability, HCTI supports hospitals, pharma, and life sciences in leveraging cutting-edge cloud and data technologies.

Sekur Private Data Ltd. (OTCQB: SWISF | CSE: SKUR), a cybersecurity provider, is positioned in the $14.5B secure communications market growing at 19.8% CAGR. Its encrypted suite for email, messaging, and VPN services targets a booming $578.2B cybersecurity landscape expected by 2033. Sekur's enterprise-grade upgrades and privacy-first model stand out in an increasingly data-vulnerable world. The company recently announced expansion efforts across eight African nations-Ethiopia, Zimbabwe, Angola, Uganda, Nigeria, Kenya, Ghana, and Mozambique-all among the most cyberattacked regions globally in early 2025.

American Diversified Holdings Corp. (OTC: ADHC) announces feedback progress on its Breakthrough Device Application, with Dr. Stephen C. Weber, MD leading its Medical Advisory Board. Dialogues with the FDA support upcoming regulatory steps. ADHC also signals forthcoming updates on strategic funding and partnerships.

NuCana plc (NASDAQ: NCNA), a clinical-stage biopharma firm, has priced a $7 million registered direct offering. The deal includes ADSs and two series of warrants, aimed at funding its cancer drug pipeline, general corporate use, and potential acquisitions. The offering is expected to close around May 7, 2025.

Additional Penny Stocks to Watch:

Yuengling's Ice Cream Corp. (OTC: YCRM), now renamed Frequency Holdings, Inc., is shifting from nostalgia to next-gen tech. Modeled after Berkshire Hathaway and Alphabet, Frequency is building a multi-brand platform spanning AI, cybersecurity, and IT infrastructure. Its flagship brand, ReachOut, aims to dominate cybersecurity-first IT for SMBs, with future growth anticipated through new subsidiaries like TRUSTLESS.

Polyrizon Ltd. (NASDAQ: PLRZ), a development-stage biotech company, is innovating in nasal spray-based medical devices. Their hydrogel platform creates a protective shield in the nasal cavity, designed to guard against viruses and allergens by preventing contact with nasal epithelial tissue-a solution aimed at improving public health resilience.

Greenlane Holdings Inc. (NASDAQ: GNLN), a major U.S. distributor of vaporization products and consumption accessories, continues to serve both B2B and direct-to-consumer markets. Its extensive portfolio includes vaporizers, grinders, rolling papers, and premium packaging solutions, reinforcing its presence across the growing lifestyle and wellness space.

From AI-driven healthcare and secure data platforms to biotech breakthroughs and digital consumer goods, HCTI, SWISF, ADHC, NCNA, YCRM, PLRZ, and GNLN reflect the dynamic innovation unfolding across small-cap markets. Investors scanning the under-$1 and under-$5 range may find compelling growth narratives and speculative upside in these emerging plays.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pennies-on-the-rise-hcti-swisf-adhc-ncna-gain-traction-amid-largecap-uncertainty-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty - More Stocks Inside here

News-ID: 4023745 • Views:

More Releases from ABNewswire

Prurigo Nodularis Market on Track for Major Expansion by 2034, According to DelveInsight | Celgene Crp., Novartis, Pfizer, Galderma, Genentech, Incyte Crp., Trevi Therapeutics, Vyne Therapeutics
Prurigo Nodularis Market on Track for Major Expansion by 2034, According to Delv …
The Key Prurigo Nodularis Companies in the market include - Trevi Therapeutics, Galderma, Genentech, Incyte Corporation, Vyne Therapeutics Inc., Celgene Corporation, Novartis, Pfizer, Regeneron Pharma, and others. DelveInsight's "Prurigo Nodularis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Prurigo Nodularis, historical and forecasted epidemiology as well as the Prurigo Nodularis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To
Non-Hodgkin Lymphoma Pipeline 2025: Mechanism of Action, Route of Administration, and Clinical Trial Insights Explored by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma
Non-Hodgkin Lymphoma Pipeline 2025: Mechanism of Action, Route of Administration …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 200+ key companies continuously working towards developing 220 + Non-Hodgkin Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Non-Hodgkin Lymphoma Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Non-Hodgkin Lymphoma Market. The Non-Hodgkin Lymphoma Pipeline
4 Stocks Poised to Thrive in the $47 Billion Cell Therapeutics Market
4 Stocks Poised to Thrive in the $47 Billion Cell Therapeutics Market
Cell-based therapeutics have come a long way from simply experimental treatments confined in labs to their current mainstream commercial success. In the past year alone, the FDA approved seven new cell therapies, bringing the total number of gene and cell therapies approved in the US to 43, with the largest segment of these products being umbilical cord blood derivatives. Unlike other treatments, cell-based therapies use modified or healthy cells to treat
Score the Cheapest Morgan Wallen 2025 Concert Tickets Online with Promo Code CITY10 at CapitalCityTickets.com
Score the Cheapest Morgan Wallen 2025 Concert Tickets Online with Promo Code CIT …
Score the cheapest Morgan Wallen 2025 I'm The Problem Tour tickets at CapitalCityTickets.com! Use promo code CITY10 for extra savings on affordable seats to 19 stadium shows, starting June 20 in Houston. Enjoy hits like "Whiskey Glasses" with guests like Miranda Lambert. Book early, compare prices, and secure your spot for an unforgettable country music experience with a 100% Buyer Guarantee! Country music superstar Morgan Wallen is hitting the road in

All 5 Releases


More Releases for HCTI

PU Coating Market 2020 Analysis by Global Manufacturers – Akzo Nobel N.V., PPG …
The PU Coating Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. This report also analyzes
Green Coating Market 2020 Strategic Assessments - Akzo Nobel, Henkel, PPG Indust …
The Green Coating Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Buy The Report: https://www.marketinsightsreports.com/report/purchase/09241478501?mode=su?source=openpr&Mode=RJ Green coatings are